ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,491 | -79.9% | 57,189 | -21.8% | 0.00% | – |
| Q2 2023 | $37,308 | +4.3% | 73,155 | +28.9% | 0.00% | – |
| Q1 2023 | $35,764 | -17.1% | 56,769 | -14.6% | 0.00% | – |
| Q4 2022 | $43,133 | -90.4% | 66,461 | -74.6% | 0.00% | – |
| Q3 2022 | $449,000 | +2038.1% | 261,272 | +1432.8% | 0.00% | – |
| Q2 2022 | $21,000 | -51.2% | 17,045 | -73.7% | 0.00% | – |
| Q1 2022 | $43,000 | -95.2% | 64,928 | -92.1% | 0.00% | – |
| Q4 2021 | $897,000 | +15.3% | 823,526 | +92.7% | 0.00% | – |
| Q3 2021 | $778,000 | -24.8% | 427,406 | +9.1% | 0.00% | – |
| Q2 2021 | $1,035,000 | +46.2% | 391,875 | +99.3% | 0.00% | – |
| Q1 2021 | $708,000 | -31.7% | 196,641 | -52.2% | 0.00% | – |
| Q4 2020 | $1,037,000 | -43.4% | 411,543 | -43.4% | 0.00% | – |
| Q3 2020 | $1,833,000 | +348.2% | 727,642 | +483.9% | 0.00% | – |
| Q2 2020 | $409,000 | +43.5% | 124,614 | +6.9% | 0.00% | – |
| Q1 2020 | $285,000 | -40.3% | 116,526 | +15.4% | 0.00% | – |
| Q4 2019 | $477,000 | -27.0% | 100,955 | -33.7% | 0.00% | – |
| Q3 2019 | $653,000 | -49.0% | 152,317 | -30.6% | 0.00% | – |
| Q2 2019 | $1,281,000 | -33.4% | 219,602 | -56.0% | 0.00% | – |
| Q1 2019 | $1,922,000 | +2084.1% | 499,109 | +972.9% | 0.00% | – |
| Q4 2018 | $88,000 | -21.4% | 46,520 | +33.7% | 0.00% | – |
| Q3 2018 | $112,000 | -62.8% | 34,806 | -65.0% | 0.00% | – |
| Q2 2018 | $301,000 | -79.4% | 99,565 | -73.3% | 0.00% | – |
| Q1 2018 | $1,460,000 | +900.0% | 372,502 | +959.4% | 0.00% | – |
| Q4 2017 | $146,000 | -24.7% | 35,161 | +11.6% | 0.00% | – |
| Q3 2017 | $194,000 | +26.8% | 31,503 | +27.5% | 0.00% | – |
| Q2 2017 | $153,000 | -97.2% | 24,703 | -97.1% | 0.00% | -100.0% |
| Q1 2017 | $5,483,000 | +27.6% | 864,802 | +7.7% | 0.00% | +100.0% |
| Q4 2016 | $4,298,000 | +483.2% | 803,327 | +514.1% | 0.00% | – |
| Q3 2016 | $737,000 | -25.3% | 130,820 | -27.1% | 0.00% | – |
| Q2 2016 | $986,000 | -28.8% | 179,566 | -3.8% | 0.00% | – |
| Q1 2016 | $1,385,000 | -57.6% | 186,700 | -52.5% | 0.00% | -100.0% |
| Q4 2015 | $3,266,000 | -46.6% | 393,015 | -42.1% | 0.00% | -50.0% |
| Q3 2015 | $6,115,000 | -33.7% | 678,638 | -11.7% | 0.00% | -33.3% |
| Q2 2015 | $9,226,000 | +456.1% | 768,847 | +399.2% | 0.00% | +200.0% |
| Q1 2015 | $1,659,000 | +127.9% | 154,028 | +7.3% | 0.00% | – |
| Q4 2014 | $728,000 | +209.8% | 143,532 | +60.6% | 0.00% | – |
| Q3 2014 | $235,000 | -59.0% | 89,379 | -37.1% | 0.00% | – |
| Q2 2014 | $573,000 | +253.7% | 142,102 | +301.7% | 0.00% | – |
| Q1 2014 | $162,000 | -3.0% | 35,378 | -8.3% | 0.00% | – |
| Q4 2013 | $167,000 | +5.7% | 38,588 | -3.7% | 0.00% | – |
| Q3 2013 | $158,000 | +236.2% | 40,067 | +77.9% | 0.00% | – |
| Q2 2013 | $47,000 | – | 22,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |